NCT01514110View on ClinicalTrials.gov

Gastric Cancer RAD001 Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 23, 2008

Primary Completion Date

March 6, 2019

Study Completion Date

March 6, 2019

Conditions
Gastric Cancer
Interventions
DRUG

RAD001

Pharmacology of RAD001 as a combination partner for conventional agents.

Trial Locations (1)

Unknown

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01514110 - Gastric Cancer RAD001 Study | Biotech Hunter | Biotech Hunter